Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Harrow, Inc. - Common Stock
(NQ:
HROW
)
40.94
+0.29 (+0.70%)
Streaming Delayed Price
Updated: 2:31 PM EDT, Apr 17, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Harrow, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
March 18, 2025
Via
Benzinga
US Futures Show Caution Among Investors Ahead Of FOMC Meeting: Analysts Say Only Certainty Is That 'Things Will Remain Uncertain For The Time Being'
↗
March 18, 2025
U.S. stock futures were flat on Tuesday after a bounce back on Monday. Futures of all four benchmark indices were mixed in premarket trading.
Via
Benzinga
Why Harrow Shares Are Trading Higher By 23%; Here Are 20 Stocks Moving Premarket
↗
March 18, 2025
Via
Benzinga
Earnings Scheduled For November 13, 2024
↗
November 13, 2024
Via
Benzinga
Earnings Outlook For Harrow
↗
November 12, 2024
Via
Benzinga
Top movers in Monday's after hours session
↗
March 17, 2025
As the regular session of the US market on Monday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Via
Chartmill
12 Health Care Stocks Moving In Monday's After-Market Session
↗
March 17, 2025
Via
Benzinga
Harrow Provides Fourth Quarter and Year-End 2024 Unaudited Preliminary Financial Results and 2025 Revenue Guidance
March 17, 2025
From
Harrow, Inc.
Via
Business Wire
Harrow Launches VEVYE® Access for All
March 17, 2025
From
Harrow, Inc.
Via
Business Wire
Earnings Scheduled For March 17, 2025
↗
March 17, 2025
Via
Benzinga
Harrow Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
↗
March 17, 2025
Via
Benzinga
Harrow Executes Five-Year Strategic Supply and Development Agreement for TRIESENCE®
March 11, 2025
From
Harrow, Inc.
Via
Business Wire
Harrow to Report Fourth Quarter and Year-End 2024 Financial Results After Market Close on March 17, 2025
March 03, 2025
From
Harrow, Inc.
Via
Business Wire
This Harrow Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
↗
February 06, 2025
Via
Benzinga
Harrow Partners with Cencora to Launch “Harrow Cares” Program, Making IHEEZO® and TRIESENCE® More Accessible and Affordable for Retina Specialists and Their Patients
January 27, 2025
From
Harrow, Inc.
Via
Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
↗
January 14, 2025
Via
Benzinga
Harrow Appoints Amir H. Shojaei as Chief Scientific Officer
January 07, 2025
From
Harrow, Inc.
Via
Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
↗
November 29, 2024
Via
Benzinga
Harrow’s ImprimisRx Subsidiary Receives $34.9 Million Unanimous Jury Verdict Award in ImprimisRx, LLC v. OSRX, Inc.
November 21, 2024
From
Harrow, Inc.
Via
Business Wire
Melt Pharmaceuticals Reports Positive Phase 3 Topline Efficacy Results for MELT-300, Its Lead Product Candidate for Opioid-Free, Sublingual Procedural Sedation in Patients Undergoing Cataract Surgery
November 20, 2024
From
Melt Pharmaceuticals, Inc.
Via
Business Wire
Harrow Announces Participation in Upcoming Investor Conferences
November 15, 2024
From
Harrow, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
November 14, 2024
Via
Benzinga
Advance Auto Parts Posts Weak Results, Joins Harrow, Taysha Gene Therapies And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
↗
November 14, 2024
Via
Benzinga
Why DLocal Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
↗
November 14, 2024
Via
Benzinga
Harrow Announces Third Quarter 2024 Financial Results
November 13, 2024
From
Harrow, Inc.
Via
Business Wire
Harrow Launches Access and Affordability Program with Price Reductions for Branded Products
November 13, 2024
From
Harrow, Inc.
Via
Business Wire
Harrow Announces Market Access Wins for VEVYE®
November 12, 2024
From
Harrow, Inc.
Via
Business Wire
Harrow Partners with Asembia to Enhance Provider and Patient Experience Through Nationwide Digital Services and Hub Support for Harrow’s Branded Eyecare Products
November 07, 2024
From
Harrow, Inc.
Via
Business Wire
Harrow To Report Third Quarter 2024 Financial Results After Market Close on November 13, 2024
October 31, 2024
From
Harrow, Inc.
Via
Business Wire
Melt Pharmaceuticals Announces Dosing of Last Patient in Pivotal Phase 3 Study of Its Lead Product Candidate, MELT-300, for Needle- and Opioid-Free Sedation in Patients Undergoing Cataract Surgery
October 10, 2024
From
Harrow, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
